New, Access

New report from Access to Medicine Foundation shows what pharma companies can do to ensure the few promising antimicrobials in development reach patients on the frontlines of drug resistance

Published on 08/07/2025 at 18:06 | prnewswire.co.uk

Access to Medicine Foundation France Germany Spain United Kingdom United States of America Netherlands New York

en | boerse | 67955047 |